FIMM and Labcyte expand collaboration
The Institute for Molecular Medicine Finland (FIMM) has extended its collaboration with biotechnology tools company Labcyte, with multiple new approaches to personalised medicine that leverage Labcyte’s acoustic liquid handling technology.
BC Platforms serves as medium for MS research
Finnish BC Platforms offers its technology solutions and research platform to Biogen and the Accelerated Cure Project (ACP) to advance research into multiple sclerosis (MS).
Finnish scientists awarded for dog gel paper
A research group led by Finnish Orion Pharma scientists have landed an award for a study paper on dexmedetomidine oromucosal gel for noise anxiety in dogs.
Biohit secures important patent in Japan
Finnish biotechnology company Biohit has been granted a patent for its Biohit Acetium Capsule in Japan. The Biohit Acetium Capsule binds acetaldehyde in the stomach and is used to treat acid-free stomach and those at risk of obtaining gastric cancer.
Finnish professor wins German science award
Professor Bjarne Udd has been honoured with the German Duchenne-Erb-Preis science award for his extensive research into neuromuscular diseases.
Finnish stroke treatment settles in Russia
The internationally awarded stroke treatment of the Hospital District of Helsinki and Uusimaa (HUS) gains attention in Russia.
Drug developed in Turku blocks a notorious cancer driver
A research group at the Turku Centre for Biotechnology has found a novel way to inhibit a particularly vicious activity of one of the most notorious cancer drivers: the oncoprotein Ras.
Finnish invention enables point-of-care microscopy
Finnish researchers have developed an affordable, compact and easily portable mobile microscope. The invention will ease the shortage of global experts, as it enables rapid remote diagnostics using artificial intelligence.
Finnish researchers and Pfizer develop targeted cancer drugs
Cancer researchers at the University of Helsinki’s Institute for Molecular Medicine Finland (FIMM) have agreed on a collaborative research project with the pharmaceutical company Pfizer. The purpose of the project is to create new targeted cancer drugs particularly for the treatment of leukaemia.
University of Helsinki reveals new information about antibiotics
A new research conducted by the University of Helsinki reveals that the use of antibiotics in early childhood interferes with normal development of the intestinal microbiota.
New thesis uncovers protective factors for psychosis
Emmi Keskinen’s doctoral thesis for the University of Oulu proves the existence of protective factors against psychosis. Protective factors have been studied very little up to now.